# Sarati International, Inc – FDA Inspection, Mar 21, 2025

Source: https://www.keypedia.com/records/fda_inspections/sarati-international-inc/62f6f22d-f711-4adc-bd2a-1db31bf4ea97
Source feed: FDA_Inspections

> FDA inspection 1256177 of Sarati International, Inc, March 21, 2025. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1256177
- Company Name: Sarati International, Inc
- Inspection Date: 2025-03-21
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1093755 - 2019-06-13](https://www.keypedia.com/records/fda_inspections/sarati-international-inc/175183c5-2d9e-4048-8153-76bf5ec7ac9c)
- [FDA Inspection 1021815 - 2017-06-30](https://www.keypedia.com/records/fda_inspections/sarati-international-inc/e6791cbf-3eba-4e42-b11e-130cc4131540)
- FDA Inspection 953924 - 2015-11-20
- [FDA Inspection 732571 - 2011-06-29](https://www.keypedia.com/records/fda_inspections/sarati-international-inc/f8113aaa-f78e-4797-8483-93e9a798c74e)
- FDA Inspection 613028 - 2009-08-31

## Related Officers

- [Investigator](https://www.keypedia.com/people/demario-l-walls/c69c4c87-f001-45ab-8d7b-b45c60226ff1)

Company: https://www.keypedia.com/companies/sarati-international-inc/046eadcd-3abf-4486-8b64-5d7ec464ac9d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c